GLIMEZIT 1000 mg, effervescent tablet 28 tablets
Active ingredients: Metformin hydrochloride, Metformin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Effervescent tablet28 tabletsorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- GLIMEZIT 1000 mg, comprimé effervescent
- Pharmaceutical form
- comprimé effervescent(e)
- Route of administration
- orale
- Presentation description
- film(s) thermosoudé(s) aluminium polyéthylène de 28 comprimé(s)
- Marketing authorisation holder
- UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES (GRECE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Oct 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63806909CIP73022227CIP133400930222270Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| METFORMINE BASEcomprimé | 780 mg · un comprimé | FT |
| CHLORHYDRATE DE METFORMINEcomprimé | 1000 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.